TRACON Pharmaceuticals, Inc. (TCON) Financials
TCON Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 10.1 million | 10.9 million |
2023-09-30 | 9.4 million | 12.5 million |
2023-06-30 | 12.2 million | 27.9 million |
2023-03-31 | 8.3 million | 19.4 million |
TCON Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -522000 | 490000 |
2023-09-30 | 15.1 million | 493000 |
2023-06-30 | -5.9 million | 502000 |
2023-03-31 | -5.0 million | 484000 |
TCON Net Income
No data available :(
TCON Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 8.6 million | - | 236000 |
2023-09-30 | 7.8 million | - | - |
2023-06-30 | 1.7 million | - | - |
2023-03-31 | 6.6 million | - | - |
TCON Shares Outstanding
TCON Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 1.5 million | 1.1 million | - |
2023-09-30 | - | 2.3 million | 1.3 million | - |
2023-06-30 | - | 3.5 million | 1.9 million | - |
2023-03-31 | - | 5.0 million | 2.3 million | - |
TCON Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 3.0 million | 3000 |
2023-09-30 | - | 4000 |
2023-06-30 | 9.0 million | 3000 |
2023-03-31 | - | 4000 |
TCON
Price: $1.85
52 week price:
Earnings Per Share: -2.20 USD
P/E Ratio: -0.45
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 47100
Ebitda: 1.4 millionMarket Capitalization: 5.4 million